Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
7.86
+0.06 (0.77%)
Nov 20, 2024, 4:00 PM EST - Market closed
Foghorn Therapeutics Market Cap
Foghorn Therapeutics has a market cap or net worth of $436.96 million as of November 21, 2024. Its market cap has increased by 196.15% in one year.
Market Cap
436.96M
Enterprise Value
208.64M
1-Year Change
196.15%
Ranking
Category
Stock Price
$7.86
Market Cap Chart
Since the IPO on October 23, 2020, Foghorn Therapeutics's market cap has decreased from $565.43M to $436.96M, a decrease of -22.72%. That is a compound annual growth rate of -6.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 436.96M | 60.47% |
| Dec 29, 2023 | 272.30M | 2.10% |
| Dec 30, 2022 | 266.70M | -68.56% |
| Dec 31, 2021 | 848.32M | 17.59% |
| Dec 31, 2020 | 721.42M | 27.59% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Allogene Therapeutics | 444.50M |
| National Research | 442.05M |
| Aquestive Therapeutics | 439.48M |
| Korro Bio | 436.84M |
| Taysha Gene Therapies | 434.48M |
| Quanterix | 424.47M |
| Rigel Pharmaceuticals | 421.18M |
| Tango Therapeutics | 413.56M |